dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
Published 7 years ago • 1K plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
10:39
fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
7:01
fda approvals in ovarian cancer and merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
1:19
dr. nghiem on response to immunotherapy in merkel cell carcinoma
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
0:50
dr. nghiem on pembrolizumab for advanced merkel cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:05
ragini kudchadkar on treating patients with basal cell carcinoma
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
1:24
emerging agents in the pipeline for merkel cell carcinoma
-
1:38
dr. lebbe discusses efficacy of avelumab in merkel cell carcinoma
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma